Hospitalization

HONOLULU — 2020 COVID-19 hospitalizations requiring extracorporeal membrane oxygenation cost significantly more and had lengthier stays than those that did not utilize ECMO, according to study results presented at the CHEST Annual Meeting.

HONOLULU — A higher comorbidity burden increases the odds for in-hospital mortality among adults with pulmonary embolism, according to a poster presented at the CHEST Annual Meeting.

HONOLULU — Risk for mortality and hospitalization did not differ between patients with idiopathic pulmonary fibrosis taking 100 mg or 150 mg nintedanib twice daily, according to a real-world analysis presented at the CHEST Annual Meeting.

HONOLULU — Patients with both eosinophilic esophagitis and asthma present to the hospital at an earlier age than those patients who only have EoE, according to an abstract presented at the CHEST Annual Meeting.

Thirty-day hospital readmissions decreased among patients in HIV care in the United States and Canada from 2005 to 2018, researchers reported.

The percentage of patients in Alberta, Canada, who received optimal care after an AKI episode was low and may signal a need to improve outcomes, according to a recently published study.

Paxlovid was associated with a significant reduction in 30-day hospitalization or death among previously uninfected patients with COVID-19 who were not hospitalized, researchers found.

The crude rate of hospitalizations for COPD in Canada increased by nearly 70% in 2017 compared with 2002, according to results published in CMAJ.

Adults hospitalized with COVID-19 were less likely to experience critical outcomes such as ICU admission, respiratory failure or death during later periods of the pandemic, researchers found.

An abuse-deterrent formulation of oxycodone resulted in decreased hospital admissions and health care costs, a study presented at PAINWeek found.